Content for healthcare professionals only

View all Platforms Journal

ICR Home About ICR Editorial Board Information for Authors Topics Current Volume Special Collections Previous Volumes Videos Submit Article

Radcliffe Platforms

Radcliffe Group Cardiology Vascular Medical Education

Content for healthcare professionals only

AER

CFR

ECR

ICR3

JAPSC

USC

ICR³is the official journal of the

About ICR

Editorial Board

For Authors

Topics

Current Volume

Special Collections

Previous Volumes

Videos

Submit Article

EuroPCR 2024: Late-Breaking Science Video Collection

Published: 20 May 2024

Views:
1043
Likes:
7

Views:
1043
Likes:
7
Share:

Now Playing
Part 3 | Session 2 of 2
4 Trials That Will Change My Practice with Dr Bernardo Cortese
Bernardo Cortese

Up Next

4m 31s

Part 1 | Session 1 Self-Expandable Vs Balloon-Expandable Valves & General Vs Local Anesthesia in TAVI: SOLVE-TAVI Hans-Josef Feistritzer

3m 44s

Part 1 | Session 2 Influence of Pathophysiological Patterns of CAD on PCI Carlos Collet

5m 19s

Part 1 | Session 3 Ancillary SMART Trial Analyses Roxana Mehran

3m 59s

Part 1 | Session 4 Impact of Diabetes Severity After Abluminus DES+ Stent: ABILITY Roxana Mehran

4m 6s

Part 1 | Session 5 TAVR Vs SAVR in Younger Low-Risk Patients with Severe Aortic Valve Stenosis: NOTION-2 Ole De Backer

26m 48s

Part 1 | Session 6 1M DAPT Followed by 5M Ticagrelor Monotherapy in ACS with DCB: CAGEFREE II Ling Tao

26m 3s

Part 2 | Session 1 View from the Thoraxcenter: What's Hot at EuroPCR 24? Joost Daemen, Nicolas M Van Mieghem

18m 29s

Part 2 | Session 2 View from the Thoraxcenter: EuroPCR 24 Wrap Up - Part 1 Joost Daemen, Nicolas M Van Mieghem

4m 13s

Part 3 | Session 1 5 Trials That Will Change My Practice With Dr Mirvat Alasnag Mirvat Alasnag

Average (ratings)

No ratings

Your rating

Overview

Our regular review series View From the Thoraxcenter, hosted by Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcentre, Erasmus MC, Rotterdam, NL) dives deep into the late-breaking trials of EuroPCR 2023, spotlighting the impactful data.

For short, concise coverage of the key data revealed, our accessible Expert Interviews were conducted with select faculty, focussing on the results, applicability and impact on future research.

Hear commentary on the practice-changing trials of EuroPCR 2024 from selected faculty in our Highlights Reviews.

More from this programme

Part 1

Expert Interviews

6 sessions
Self-Expandable Vs Balloon-Expandable Valves & General Vs Local Anesthesia in TAVI: SOLVE-TAVI	Watch now
Influence of Pathophysiological Patterns of CAD on PCI	Watch now
Ancillary SMART Trial Analyses	Watch now
Impact of Diabetes Severity After Abluminus DES+ Stent: ABILITY	Watch now
TAVR Vs SAVR in Younger Low-Risk Patients with Severe Aortic Valve Stenosis: NOTION-2	Watch now
1M DAPT Followed by 5M Ticagrelor Monotherapy in ACS with DCB: CAGEFREE II	Watch now

Part 2

View from the Thoraxcenter

2 sessions
View from the Thoraxcenter: What's Hot at EuroPCR 24?	Watch now
View from the Thoraxcenter: EuroPCR 24 Wrap Up - Part 1	Watch now

Part 3

Highlights Reviews

2 sessions
5 Trials That Will Change My Practice With Dr Mirvat Alasnag	Watch now
4 Trials That Will Change My Practice with Dr Bernardo Cortese	Watch now

About the episode

EuroPCR 2024 - We are joined by Dr Bernardo Cortese (Ospedale Fate bene Fratelli, IT) for a concise and insightful summary of the late-breaking trials that are expected to have an impact on structural heart disease care.

Trials covered in detail include:

LANDMARK
ABILITY
CAGEFREE II
PICCOLETO VI

Recorded remotely onsite at EuroPCR 2024, Paris

Faculty Biographies

Bernardo Cortese

Bernardo Cortese

Dr Bernardo Cortese is Consultant Interventional Cardiologist for coronary and structural heart disease at the Columbus Clinic in Milano, and the Vercelli Hospital in Italy. He is the CEO of the DCB Academy, and Director of Cardiology at Clinical San Carlo in Milano.

View full profile

Comments

You must be to comment. If you are not registered, you can register here.